UK strategy of backing several Covid vaccines seems to be paying off

Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issuesCoronavirus – latest updatesSee all our coronavirus coverageThe government has said the decision by Johnson& Johnson todelay the supply of its Covid vaccine to Europe, while theUS investigates reports of six cases of unusual blood clots in young women who have had the jab, will not derail the UK ’s vaccination programme.That reflects well on the decisions taken by the Vaccines Taskforce, originally headed by Kate Bingham.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Vaccines and immunisation Coronavirus UK news Health policy Infectious diseases Science AstraZeneca Pharmaceuticals industry Medical research Source Type: news